May 31 |
Insider Sale: Chief Scientific Officer Stephen Betz Sells 3,000 Shares of Crinetics ...
|
May 30 |
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
|
May 23 |
Crinetics: Earlier Data Release For CAH Treatment Bodes Well For Upcoming Conference Data
|
May 22 |
Crinetics Pharma gains after early release of study data
|
May 22 |
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
|
May 13 |
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
|
May 11 |
Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three years
|
May 11 |
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2024 Earnings Call Transcript
|
May 10 |
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 10 |
Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results
|